@flightact4
actief 2 maanden, 2 weken geleden
Introduction Sodium-glucose cotransporter type 2 inhibitors (SGLT2is) have a complex relationship with the kidney so that their use in patients with type 2 diabetes (T2DM) and diabetic kidney disease (DKD) has long been challenged.Areas covered SGLT2is in patients with DKD are discussed renal mechanisms of action, PK/PD characteristics, […] Bekijken
Member's groups
Er zijn geen groepen gevonden.